Search

everythinglearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Tofacitinib is effective and safe for treating severe alopecia areata.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Low vitamin D levels may worsen or cause alopecia areata.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

A child's hair loss from alopecia areata was fully reversed in five months using diet and supplements.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.